A high-throughput screening identifies histone deacetylase inhibitors as therapeutic agents against medulloblastoma

BACKGROUND: Medulloblastoma is the most frequently occurring malignant brain tumor in children. Current treatment strategies for medulloblastoma include aggressive surgery, cranio-spinal irradiation and adjuvant chemotherapy. Because current treatments can cause severe long-term side effects and are...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Exp Hematol Oncol
Päätekijät: Zhang, Shanshan, Gong, Zhaojian, Oladimeji, Peter O., Currier, Duane G., Deng, Qipan, Liu, Ming, Chen, Taosheng, Li, Yong
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2019
Aiheet:
Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6858705/
https://ncbi.nlm.nih.gov/pubmed/31788346
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40164-019-0153-x
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia